Filter
2210
Filtered Results: 2210
Text search:
drug
interactions
Featured
Recommendations
216
New Publications
541
Language
Document type
No document type
1433
Guidelines
274
Studies & Reports
272
Manuals
100
Strategic & Response Plan
48
Training Material
39
Fact sheets
31
Situation Updates
9
Resource Platforms
2
Infographics
2
Countries / Regions
India
128
Kenya
71
Global
69
South Africa
61
Ethiopia
49
Western and Central Europe
48
Nigeria
44
Nepal
43
Uganda
42
Tanzania
39
Sierra Leone
35
Malawi
35
Liberia
33
Zambia
29
Latin America and the Carribbean
29
Africa
28
Ghana
26
Bangladesh
26
Ukraine
23
Myanmar / Burma
22
Rwanda
21
Namibia
21
Eastern Europe
19
Russia
16
Philippines
15
Cambodia
15
Botswana
15
Lesotho
15
South–East Asia Region
14
Zimbabwe
11
Asia
11
Congo, Democratic Republic of
10
Eswatini/ Swaziland
9
USA
8
Syria
8
Mozambique
8
Indonesia
7
West and Central Africa
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Germany
6
South Sudan
5
Brazil
5
East and Southern Africa
5
Tajikistan
5
Haiti
4
Pakistan
4
Afghanistan
4
Thailand
4
Georgia
4
Guinea
3
Burkina Faso
3
Cameroon
3
Chile
3
Western Pacific Region
3
Albania
3
Laos
3
Vietnam
3
United Kingdom
3
Senegal
2
Iraq
2
Sudan
2
Argentina
2
Peru
2
North Macedonia
2
Colombia
2
Sri Lanka
2
Yemen
2
Armenia
2
Southern Africa
2
Kyrgyzstan
2
Kazakhstan
2
North America
2
Turkey
1
Gambia
1
China
1
Ireland
1
Papua New Guinea
1
Benin
1
Austria
1
Switzerland
1
El Salvador
1
Bolivia
1
Libya
1
Madagascar
1
Mexico
1
Solomon Islands
1
Venezuela
1
Palestine
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Iran
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
763
Clinical Guidelines
236
Public Health
132
Women & Child Health
71
Capacity Building
48
Key Resources
35
Pharmacy & Technologies
11
Toolboxes
Mental Health
321
HIV
256
TB
223
COVID-19
97
AMR
86
Pharmacy
62
NTDs
59
NCDs
50
Caregiver
44
Disability
39
Planetary Health
38
Ebola
32
Global Health Education
30
Rapid Response
28
Refugee
20
Conflict
13
Polio
10
Specific Hazards
8
Social Ethics
8
Health Financing Toolbox
6
Cholera
5
Natural Hazards
5
Zika
2
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
event-based surveillance (EBS) using a multisectoral, One Health approach. To ...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
